Table 3.
Selected randomized clinical trials evaluating intensification of postinduction therapy for patients with higher-risk ALL
CR, Complete remission; MTX, methotrexate; and PPR, pathological partial response.
Selected randomized clinical trials evaluating intensification of postinduction therapy for patients with higher-risk ALL
CR, Complete remission; MTX, methotrexate; and PPR, pathological partial response.
